Showing results (991-1000 of 1,205) with videos related to
Sort By:
Pageof 121
European Journal of Pharmacology|December 30, 1996
The neuropeptide Y Y1 receptor selective radioligand, [125I][Leu31,Pro34]peptide YY, is also a high affinity radioligand for human pancreatic polypeptide 1 receptorsD R Gehlert, S L Gackenheimer, D A Schober, et al.BMJ Open|October 24, 2024
Breast and endometrial safety of micronised progesterone versus norethisterone acetate in menopausal hormone therapy (PROBES): study protocol of a double-blind randomised controlled trialChristina Lundell, Nikolaos Stergiopoulos, Liselott Blomberg, et al.Pediatric Pulmonology|March 1, 1987
Changes in cerebrospinal fluid homovanillic acid in children with Ondine's curseJ Hedner, T Hedner, G R Breese, et al.Bioorganic & Medicinal Chemistry Letters|February 7, 2009
Fluoroalkyl alpha side chain containing 3,4-diamino-cyclobutenediones as potent and orally bioavailable CXCR2-CXCR1 dual antagonistsPurakkattle Biju, Arthur G Taveras, Michael P Dwyer, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 12, 2012
Infant B cell memory differentiation and early gut bacterial colonizationAnna-Carin Lundell, Viktor Björnsson, Annika Ljung, et al.Brain Communications|September 21, 2020
Disentangling white-matter damage from physiological fibre orientation dispersion in multiple sclerosisKasper Winther Andersen, Samo Lasič, Henrik Lundell, et al.The Spine Journal : Official Journal of the North American Spine Society|August 24, 2019
In vitro and in vivo evaluation of discogenic cells, an investigational cell therapy for disc degenerationLara Ionescu Silverman, Galina Dulatova, Terry Tandeski, et al.International Journal of Colorectal Disease|February 1, 1987
Two randomised phase II trials of intermittent intravenous versus subcutaneous alpha-2 interferon alone (trial 1) and in combination with 5-fluorouracil (trial 2) in advanced colorectal cancerP I Clark, M L Slevin, R H Reznek, et al.Molecular Pharmacology|July 1, 1996
Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptorD R Gehlert, D A Schober, L Beavers, et al.Journal of Inflammation (London, England)|November 13, 2009
CCR2 and CXCR4 regulate peripheral blood monocyte pharmacodynamics and link to efficacy in experimental autoimmune encephalomyelitisYuanfan Wang, Long Cui, Waldemar Gonsiorek, et al.Pageof 121